Long-term use of PCSK9i reduces CV events, including CV death

3' education - Aug. 29, 2022 - Michelle O'Donoghue, MD - Boston, MA, USA

Educational information

This video was recorded during the ESC Congress 2022 in Barcelona, Spain.

Faculty

Michelle O'Donoghue, MD is a cardiovascular medicine specialist at Brigham and Women’s Hospital and Associate Professor of Medicine at Harvard Medical School, Boston, MA, USA.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.